|
Copper drugs can block cancer growth
Business Standard “Oral drugs used to lower copper levels in Wilson disease could be repurposed to treat BRAF-driven cancers like melanoma, or perhaps even others like thyroid or lung cancer,” said Donita C Brady, lead author of the study. A clinical trial has already … |
Study may help heart failure through the Parachute Ventricular Partitioning Device – Medical Xpress
Medical Xpress |
Study may help heart failure through the Parachute Ventricular Partitioning Device
Medical Xpress Zachary Gertz, M.D., of Virginia Commonwealth University’s Pauley Heart Center is leading a new study at VCU to monitor the effects of the Parachute Ventricular Partitioning Device, which may help in the treatment of heart failure. The trial will … Study may help heart failure through Parachute DeviceHealthCanal.com |
ProMetic's PBI-4050 Delivers New Positive Preclinical Results in Liver … – SYS-CON Media (press release)
|
ProMetic’s PBI-4050 Delivers New Positive Preclinical Results in Liver …
SYS-CON Media (press release) Liver transplantation is the only treatment available for patients with advanced stage of fibrosis. About ProMetic Life Sciences Inc. ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally … |
BioLineRx Announces Investigator-Initiated Study for Novel Chronic Myeloid … – MarketWatch
BioLineRx Announces Investigator-Initiated Study for Novel Chronic Myeloid …MarketWatchPre-clinical studies show that BL-8040 is efficient, both alone and in combination with anti-cancer drugs such as Rituximab, Imatinib and Bortezomib in lymphoma, C…
BioLineRx (BLRX) Approved to Evaluate BL-8040 as CML Treatment in Phase 1 … – StreetInsider.com (subscription)
|
BioLineRx (BLRX) Approved to Evaluate BL-8040 as CML Treatment in Phase 1 …
StreetInsider.com (subscription) BioLineRx (Nasdaq: BLRX) announced that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx’s BL-8040 as a … |
ProMetic's PBI-4050 Delivers New Positive Preclinical Results in Liver … – MENAFN.COM
|
ProMetic’s PBI-4050 Delivers New Positive Preclinical Results in Liver …
MENAFN.COM Liver transplantation is the only treatment available for patients with advanced stage of fibrosis. About ProMetic Life Sciences Inc. ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally … |
Novel prediction model improves patient outcomes after paracetamol-induced … – News-Medical.net
|
Novel prediction model improves patient outcomes after paracetamol-induced …
News-Medical.net … the European Association for the Study of the Liver and Associate Professor of Medicine, University of Vienna, Austria commented: “Acute liver failure is a devastating condition that triggers a cascade of events that can lead to multiple organ … New prediction model to improve patient survival after paracetamol-related …Medical Xpress |
Know Your Madisonian: Dr. Dan Resnick – Madison.com
Know Your Madisonian: Dr. Dan ResnickMadison.comA: We are currently involved in some stem cell transplant studies for multiple sclerosis and we have participated in other drug studies for spinal cord injury, but there is really no medical game-changer …
BioLineRx Announces Investigator-Initiated Study for Novel Chronic Myeloid … – Business Wire (press release)
BioLineRx Announces Investigator-Initiated Study for Novel Chronic Myeloid …Business Wire (press release)Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with anti-cancer drugs such as Rituximab, Imatinib and Bortezo…
Your Good Health: Therapies for low bone density can be effective – Times Colonist
|
Your Good Health: Therapies for low bone density can be effective
Times Colonist Unfortunately, we do not have any way to reliably prevent Type 1 diabetes, although studies with drugs that modulate the immune system have shown early promise. Pancreas transplantation, and even islet cell transplant, can “cure” Type 1 diabetes … |